BU-NOT-SET

CONTACT US
Enhancing the production of RNA with continuous manufacturing
  • Biologics
Continuous manufacturing of RNA
Insight
GERTEIS MINI-PACTOR® Advanced dry granulation services
  • Drug product
GERTEIS MINI-PACTOR®
Fact sheet
Overcoming oncolytic virus therapy production challenges through collaboration
  • Biologics
Oncolytic virus therapy production
Case study
Emerging trends set to impact drug development in 2024
  • Industry trends
Trends in drug development
Insight
Webinar: ATMPs in focus: Essential CMC strategies for every phase
  • Biologics
ATMPs in focus
Webinar
Trends set to make an impact on oral solid dose development in 2024
  • Drug product
  • Industry trends
Oral solid dose
Insight
Enhancing AAV therapy development and manufacture with a platform approach
  • Biologics
Enhancing AAV therapy
Insight
Challenges and solutions to enhancing mRNA stability with lyophilisation processes
  • Drug product
  • Industry trends
Lyo
Insight
A well-equipped CDMO for OSD contract manufacturing
  • Industry trends
  • Manufacturing
OSD contract manufacturing
Insight
Insight
How CDMO partnerships can accelerate vaccine development
Insight
  • Analytical chemistry
  • Drug product
Optimising extractables and leachables testing
Fact sheet
  • Drug product
  • Manufacturing
Ready-to-use (RTU) pre-filled syringes and cartridges system
Insight
  • Drug product
  • Manufacturing
Recipharm’s latest investment will help meet blow-fill-seal (BFS) demand
Insight
  • Drug product
  • Industry trends
Which biologics trends in the OSD space are set to impact drug development in 2023?
Insight
  • Drug product
  • Industry trends
What are the key learnings from 2022 in pharma?
Insight
  • Drug product
  • Manufacturing
Overcoming the pitfalls of pre-filled syringe filling
Insight
  • Drug product
  • Industry trends
2023: fill and finish demand expected to continue as the industry faces new challenges
Insight
  • Drug product
  • Industry trends
What does 2023 hold for oral solid dosage forms?